Latest News about Non/Hallucinogenic Psychedelic Compound
Recent news which mentions Non/Hallucinogenic Psychedelic Compound
From Benzinga
Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines
June 27, 2023
Tickers
DSNKY
From Benzinga
From Benzinga
BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
June 09, 2023
From Benzinga
From Benzinga
Another Win For Non-Hallucinogens: Meet Psilera's Candidates Poised For Clinical Stage Milestone
March 30, 2023
From Benzinga
Mood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic Psychedelic
March 09, 2023
Tickers
BETRF
From Benzinga
BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
January 26, 2023
Tickers
BETRF
From Benzinga
Ceruvia Lifesciences Begins Dosing Volunteers In Research On Non Hallucinogenic LSD Compound
January 19, 2023
From Benzinga
Psychedelics & Role Of Memory In Healing Process, New Trial Led By Univ. Of Wisconsin
November 10, 2022
From Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
September 27, 2022
Tickers
BETRF
From Benzinga
This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects
August 31, 2022
Tickers
MSSTF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.